The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: Correlation with 18F-flurodeoxyglucose positron-emission tomography

Neuroscience Letters

Volumn 584, Issue , 2015, Pages 296-301

  Yoon, Ra Gyoung ^a   Kim, Sang Joon ^a   Kim, Ho Sung ^a   Choi, Choong Gon ^a   Kim, Jae Seung ^a   Oh, Jungsu ^a   Chung, Sun J ^a   Lee, Chong Sik ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

18F FDG PET; Brain iron deposition; Multiple system atrophy; Parkinson's disease; Susceptibility weighted imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE METABOLISM; HUMAN; INTERMETHOD COMPARISON; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PARKINSON DISEASE; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; PUTAMEN; RETROSPECTIVE STUDY; SHY DRAGER SYNDROME; SUSCEPTIBILITY WEIGHTED IMAGING; DIAGNOSTIC USE; DIFFERENTIAL DIAGNOSIS; METABOLISM; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONIAN DISORDERS; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; PARKINSONIAN DISORDERS; POSITRON-EMISSION TOMOGRAPHY; PUTAMEN; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES;

EID: 84918835391     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.10.046     Document Type: Article

References (37)

1. Aquino D., Bizzi A., Grisoli M., Garavaglia B., Bruzzone M.G., Nardocci N., Savoiardo M., Chiapparini L. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009, 252:165-172.
2. Thomas M., Jankovic J. Neurodegenerative disease and iron storage in the brain. Curr. Opin. Neurol. 2004, 17:437-442.
3. Dexter D.T., Carayon A., Javoy-Agid F., Agid Y., Wells F.R., Daniel S.E., Lees A.J., Jenner P., Marsden C.D. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991, 114(Pt 4):1953-1975.
4. Youdim M.B., Ben-Shachar D., Riederer P. The possible role of iron in the etiopathology of Parkinson's disease. Mov. Disorders 1993, 8:1-12.
5. Burton W.O., Burger P.D., Johnson P., Herfkens A., Riederer R., Parkinson S. Plus syndrome: diagnosis using high field MR imaging of brain iron. Radiology 1986, 493-498.
6. Dexter D.T., Jenner P., Schapira A.H., Marsden C.D. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group. Ann. Neurol. Suppl. 1992, 32:S94-100.
7. Ye F.Q., Allen P.S., Martin W.R. Basal ganglia iron content in Parkinson's disease measured with magnetic resonance. Mov. Disorders 1996, 11:243-249.
8. Litvan I., Goetz C.G., Jankovic J., Wenning G.K., Booth V., Bartko J.J., McKee A., Jellinger K., Lai E.C., Brandel J.P., Verny M., Chaudhuri K.R., Pearce R.K., Agid Y. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch. Neurol. 1997, 54:937-944.
9. Poewe W., Wenning G. The differential diagnosis of Parkinson's disease. Eur. J. Neurol. 2002, 9(Suppl. 3):23-30.
10. Antonini A., Leenders K.L., Vontobel P., Maguire R.P., Missimer J., Psylla M., Gunther I. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. Brain 1997, 120(Pt 12):2187-2195.
11. Ghaemi M., Hilker R., Rudolf J., Sobesky J., Heiss W.D. Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging. J. Neurol. Neurosurg. Psychiatry 2002, 73:517-523.
12. Taniwaki T., Nakagawa M., Yamada T., Yoshida T., Ohyagi Y., Sasaki M., Kuwabara Y., Tobimatsu S., Kira J. Cerebral metabolic changes in early multiple system atrophy: a PET study. J. Neurol. Sci. 2002, 200:79-84.
13. Zhang J., Zhang Y., Wang J., Cai P., Luo C., Qian Z., Dai Y., Feng H. Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study. Brain Res. 2010, 1330:124-130.
14. Haller S., Badoud S., Nguyen D., Barnaure I., Montandon M.L., Lovblad K.O., Burkhard P. Differentiation between Parkinson disease and other forms of Parkinsonism using support vector machine analysis of susceptibility-weighted imaging (SWI): initial results. Eur. Radiol. 2012.
15. Wang Y., Butros S.R., Shuai X., Dai Y., Chen C., Liu M., Haacke E.M., Hu J., Xu H. Different iron-deposition patterns of multiple system atrophy with predominant Parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging. AJNR Am. J. Neuroradiol. 2012, 33:266-273.
16. Gupta D., Saini J., Kesavadas C., Sarma P.S., Kishore A. Utility of susceptibility-weighted MRI in differentiating Parkinson's disease and atypical parkinsonism. Neuroradiology 2010, 52:1087-1094.
17. Gilman S., Low P., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C., Kaufmann H., Klockgether T., Lang A., Lantos P., Litvan I., Mathias C., Oliver E., Robertson D., Schatz I., Wenning G. Consensus statement on the diagnosis of multiple system atrophy. Am. Auton. Soc. Am. Acad. Neurol. Clin. Auton. Res. 1998, 8:359-362.
18. Litvan I., Bhatia K.P., Burn D.J., Goetz C.G., Lang A.E., McKeith I., Quinn N., Sethi K.D., Shults C., Wenning G.K. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov. Disorders 2003, 18:467-486.
19. Liu G., Sobering G., Duyn J., Moonen C.T. A functional MRI technique combining principles of echo-shifting with a train of observations (PRESTO). Magn. Reson. Med. 1993, 30:764-768.
20. Liu G., Sobering G., Olson A.W., van Gelderen P., Moonen C.T. Fast echo-shifted gradient-recalled MRI: combining a short repetition time with variable T2* weighting. Magn. Reson. Med. 1993, 30:68-75.
21. Moonen C.T., Barrios F.A., Zigun J.R., Gillen J., Liu G., Sobering G., Sexton R., Woo J., Frank J., Weinberger D.R. Functional brain MR imaging based on bolus tracking with a fast T2*-sensitized gradient-echo method. Magn. Reson. Imaging 1994, 12:379-385.
22. Rorden C., Brett M. Stereotaxic display of brain lesions. Behav. Neurol. 2000, 12:191-200.
23. Viallon M., Altrichter S., Pereira V.M., Nguyen D., Sekoranja L., Federspiel A., Kulcsar Z., Sztajzel R., Ouared R., Bonvin C., Pfeuffer J., Lovblad K.O. Combined use of pulsed arterial spin-labeling and susceptibility-weighted imaging in stroke at 3T. Eur. Neurol. 2010, 64:286-296.
24. Haller S., Badoud S., Nguyen D., Barnaure I., Montandon M.L., Lovblad K.O., Burkhard P.R. Differentiation between Parkinson disease and other forms of Parkinsonism using support vector machine analysis of susceptibility-weighted imaging (SWI): initial results. Eur. Radiol. 2013, 23:12-19.
25. Fearnley J.M., Lees A.J. Striatonigral degeneration. A clinicopathological study. Brain 1990, 113(Pt 6):1823-1842.
26. Kurisaki H., Yomono H., Murayama S., Hebisawa A. Multiple system atrophy with a-/hypo-ceruloplasminemia: distribution of iron in brains of 2 autopsy cases. Rinsho Shinkeigaku 2002, 42:293-298.
27. Spokes E.G., Bannister R., Oppenheimer D.R. Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases. J. Neurol. Sci. 1979, 43:59-82.
28. Lantos P.L., Papp M.I. Cellular pathology of multiple system atrophy: a review. J. Neurol. Neurosurg. Psychiatry 1994, 57:129-133.
29. von Lewinski F., Werner C., Jorn T., Mohr A., Sixel-Doring F., Trenkwalder C. T2*-weighted MRI in diagnosis of multiple system atrophy. A practical approach for clinicians. J. Neurol. 2007, 254:1184-1188.
30. Vymazal J., Righini A., Brooks R.A., Canesi M., Mariani C., Leonardi M., Pezzoli G. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 1999, 211:489-495.
31. Bosman T., Van Laere K., Santens P. Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease. Eur. J. Nucl. Med. Mol. Imaging 2003, 30:16-24.
32. Van Laere K., Santens P., Bosman T., De Reuck J., Mortelmans L., Dierckx R. Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters Journal of nuclear medicine: official publication. Soc. Nucl. Med. 2004, 45:933-942.
33. Nicoletti G., Lodi R., Condino F., Tonon C., Fera F., Malucelli E., Manners D., Zappia M., Morgante L., Barone P., Barbiroli B., Quattrone A. Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy. Brain: A J. Neurol. 2006, 129:2679-2687.
34. Tsukamoto K., Matsusue E., Kanasaki Y., Kakite S., Fujii S., Kaminou T., Ogawa T. Significance of apparent diffusion coefficient measurement for the differential diagnosis of multiple system atrophy, progressive supranuclear palsy, and Parkinson's disease: evaluation by 3.0-T MR imaging. Neuroradiology 2012, 54:947-955.
35. Eidelberg D., Takikawa S., Moeller J.R., Dhawan V., Redington K., Chaly T., Robeson W., Dahl J.R., Margouleff D., Fazzini E., et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann. Neurol. 1993, 33:518-527.
36. Kwon K.Y., Choi C.G., Kim J.S., Lee M.C., Chung S.J. Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease. Mov. Disorders 2007, 22:2352-2358.
37. Varrone A., Marek K.L., Jennings D., Innis R.B., Seibyl J.P. [(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy. Mov. Disorders 2001, 16:1023-1032.